{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:49:05Z","timestamp":1780433345254,"version":"3.54.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T00:00:00Z","timestamp":1121212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T00:00:00Z","timestamp":1121212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00253-005-0062-2","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T18:17:22Z","timestamp":1121192242000},"page":"456-466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Microbiological control in stem cell banks: approaches to standardisation"],"prefix":"10.1007","volume":"68","author":[{"given":"Fernando","family":"Cobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn N.","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificaci\u00f3n","family":"Catalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Barnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Concha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,7,13]]},"reference":[{"key":"62_CR1","volume-title":"Standards for tissue banking","author":"American Association of Tissue Banks","year":"2002","unstructured":"American Association of Tissue Banks (2002) Standards for tissue banking, 10th edn. American Association of Tissue Banks, McLean, VA","edition":"10"},{"key":"62_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1537-2995.2005.04267.x","volume":"45","author":"DM Arnold","year":"2005","unstructured":"Arnold DM, Neame PB, Meyer RM, Soamboonsrup P, Luinstra KE, O'hoski P, Garner J, Foley R (2005) Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection. Transfusion 45:394\u2013398","journal-title":"Transfusion"},{"key":"62_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nbt0390-233","volume":"8","author":"T Barry","year":"1990","unstructured":"Barry T, Powell R, Gannon F (1990) A general method to generate DNA probes for microorganisms. Biotechnology 8:233\u2013236","journal-title":"Biotechnology"},{"key":"62_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A","volume":"53","author":"P Cassinotti","year":"1997","unstructured":"Cassinotti P, Burtonboy G, Fopp M, Siegl C (1997) Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53:229\u2013232","journal-title":"J Med Virol"},{"key":"62_CR5","first-page":"281","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","unstructured":"Centers for Disease Control and Prevention (2004) West Nile virus screening of blood donations and transfusion associated transmission\u2014United States, 2003. MMWR Morb Mortal Wkly Rep 53:281\u2013284","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"62_CR6","volume-title":"Selection criteria in the organ donors respect to transmission of infections","author":"Consensus Document","year":"1999","unstructured":"Consensus Document (1999) Selection criteria in the organ donors respect to transmission of infections. Grupo GESITRA (SEIMC), Spain"},{"key":"62_CR7","first-page":"155","volume":"78","author":"N Dellepiane","year":"2000","unstructured":"Dellepiane N, Griffiths E, Milstien JB (2000) New challenges in assuring vaccine quality. Bull World Health Organ 78:155\u2013162","journal-title":"Bull World Health Organ"},{"key":"62_CR8","volume-title":"Guidance on the microbiological safety of human organs, tissues and cells used in transplantation. Advisory committee on the Microbiological Safety of Blood and Tissues for Transplantation, MSBT","author":"Department of Health","year":"2000","unstructured":"Department of Health (2000) Guidance on the microbiological safety of human organs, tissues and cells used in transplantation. Advisory committee on the Microbiological Safety of Blood and Tissues for Transplantation, MSBT. Department of Health, London, UK"},{"key":"62_CR9","volume-title":"A code of practice for tissue banks","author":"Department of Health","year":"2001","unstructured":"Department of Health (2001) A code of practice for tissue banks. Department of Health, London, UK"},{"key":"62_CR10","unstructured":"Directive 2004\/23\/CE of the European parliament and the council of March 31st, relating to the establishment of quality and safety norms to donate, to obtain, to assess, to process, to preserve, to store and to distribute cells and human tissues"},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0167-7799(99)01334-7","volume":"17","author":"O Doblhoff-Dier","year":"1999","unstructured":"Doblhoff-Dier O, Bachmayer H, Bennett A, Brunius G, Burki K, Cantley M, Collins C, Crooy P, Elmqvist A, Frontali-Botti C, Havenacer R, Haymerle H, Lelieveld H, Lex M, Mahler JL, Martinez L, Mosgaard C, Olsen L, Pazlarova J, Rudan F, Sarvas M, Stepankova H, Tzotzus G, Wagner K, Werner R (1999) Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms. The safety in Biotechnology Working Party of the European Federation of Biotechnology. Trends Biotechnol 17:307\u2013311","journal-title":"Trends Biotechnol"},{"key":"62_CR12","first-page":"19","volume":"102","author":"RY Dodd","year":"2000","unstructured":"Dodd RY, Stramer JL, Aberle-Grasse J, Notari E IV (2000) Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT). Dev Biol Stand 102:19\u201327","journal-title":"Dev Biol Stand"},{"key":"62_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","volume":"42","author":"RY Dodd","year":"2002","unstructured":"Dodd RY, Notari EP IV, Stramer SL (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42:975\u2013979","journal-title":"Transfusion"},{"key":"62_CR14","volume-title":"Cell and tissue culture: laboratory procedures in biotechnology","author":"A Doyle","year":"1998","unstructured":"Doyle A, Griffiths JB (1998) Elimination of contamination. In: Cell and tissue culture: laboratory procedures in biotechnology. Wiley, New York"},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1022913015916","volume":"39","author":"HG Drexler","year":"2002","unstructured":"Drexler HG, Uphoff CC (2002) Mycoplasma contamination of cell cultures. Incidence, sources, effects, detection, elimination, prevention. Cytotechnology 39:75\u201390","journal-title":"Cytotechnology"},{"key":"62_CR16","volume-title":"Manufacture of sterile medicinal products, revision to annex 1","author":"EC Guide to Good Manufacturing Practice","year":"2003","unstructured":"EC Guide to Good Manufacturing Practice (2003) Manufacture of sterile medicinal products, revision to annex 1. EC, Brussels"},{"key":"62_CR17","volume-title":"ICH Consensus guideline on quality of biotechnology products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin, publication no CPMP\/ICH\/295\/95","author":"European Medicines Evaluation Agency","year":"1997","unstructured":"European Medicines Evaluation Agency (1997) ICH Consensus guideline on quality of biotechnology products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin, publication no CPMP\/ICH\/295\/95. European Medicines Evaluation Agency, Canary Wharf, London"},{"key":"62_CR18","volume-title":"EMEA workshop on application of pharmaceutical assays for markers of TSE: report to CPMP from the BIOT-WP (CPMP\/BWP\/257\/99)","author":"European Medicines Evaluation Agency","year":"1999","unstructured":"European Medicines Evaluation Agency (1999) EMEA workshop on application of pharmaceutical assays for markers of TSE: report to CPMP from the BIOT-WP (CPMP\/BWP\/257\/99). EMEA, London"},{"key":"62_CR19","volume-title":"Note for guidance on the use of bovine serum in the manufacture on human biological medicinal products","author":"European Medicines Evaluation Agency","year":"2003","unstructured":"European Medicines Evaluation Agency (2003) Note for guidance on the use of bovine serum in the manufacture on human biological medicinal products. EMEA, London"},{"key":"62_CR20","unstructured":"European Pharmacopeia (2002) Pharmaceutical inspection convention. Recommendation on sterility testing, PIC\/s"},{"key":"62_CR21","volume-title":"European Pharmacopeia section 2.6.1 (Sterility)","author":"European Pharmacopeia","year":"2004","unstructured":"European Pharmacopeia (2004a) European Pharmacopeia section 2.6.1 (Sterility). Maisonneuve SA, Sainte Ruffine"},{"key":"62_CR22","volume-title":"European Pharmacopeia section 2.6.7 (Mycoplasma)","author":"European Pharmacopeia","year":"2004","unstructured":"European Pharmacopeia (2004b) European Pharmacopeia section 2.6.7 (Mycoplasma). Maisonneuve SA, Sainte Ruffine"},{"key":"62_CR23","first-page":"113","volume":"27","author":"R Fanci","year":"2004","unstructured":"Fanci R, De Santis R, Zakrzewska K, Paci C, Azzi A (2004) Presence of TT virus DNA in bone marrow cells from hematologic patients. New Microbiol 27:113\u2013117","journal-title":"New Microbiol"},{"key":"62_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00228597","volume":"39","author":"W Frommer","year":"1993","unstructured":"Frommer W, Archer L, Boon B, Brunius G, Collins CH, Crooy P, Doblhoff-Dier O, Donikian R, Economidis J, Frontali C (1993) Safe biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogens. Appl Microbiol Biotechnol 39:141\u2013147","journal-title":"Appl Microbiol Biotechnol"},{"key":"62_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/039463200301600204","volume":"16","author":"AR Garbuglia","year":"2003","unstructured":"Garbuglia AR, Iiezzi T, Capobianchi MR, Pignoloni P, Pulsoni A, Sourdis J, Pescarmona E, Vitolo D, Mandelli F (2003) Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int J Immunopathol Pharmacol 16:109\u2013118","journal-title":"Int J Immunopathol Pharmacol"},{"key":"62_CR26","volume-title":"Rules and guidance for pharmaceutical manufacturers and distributors (EEC Orange Guide)","author":"GPMD","year":"2002","unstructured":"GPMD (2002) Rules and guidance for pharmaceutical manufacturers and distributors (EEC Orange Guide). The Stationery Office, London"},{"key":"62_CR27","first-page":"407","volume":"30","author":"T Hartung","year":"2002","unstructured":"Hartung T, Balls M, Bardouille C, Blank O, Coecke S, Gstramthaler G, Lewis D (2002) Good cell culture practice. ECVAM Good Cell Culture Practice Task Force Report 1. ATLA 30:407\u2013411","journal-title":"ATLA"},{"key":"62_CR28","first-page":"219","volume":"47","author":"WE Hitzler","year":"2001","unstructured":"Hitzler WE, Runkel S (2001) Screening of blood donations by hepatitis C virus polymerase chain reaction (HCV-PCR) improves safety of blood products by window period reduction. Clin Lab 47:219\u2013222","journal-title":"Clin Lab"},{"key":"62_CR29","volume-title":"ICH harmonised tripartite guideline. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1997","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1997) ICH harmonised tripartite guideline. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH, Geneva"},{"key":"62_CR30","unstructured":"International Organization for Standarization (1999) ISO 14644. Cleanrooms and associated controlled environments. Part 1: Classification of air cleanliness. International Organization for Standarization"},{"key":"62_CR31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1750-3639.1996.tb00869.x","volume":"6","author":"JW Ironside","year":"1996","unstructured":"Ironside JW (1996) Review: Creutzfeldt\u2013Jakob disease. Brain Pathol 6:379\u2013388","journal-title":"Brain Pathol"},{"key":"62_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jama.280.1.42","volume":"280","author":"RS Janssen","year":"1998","unstructured":"Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP (1998) New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42\u201348 (Erratum, JAMA 1999; 281: 1893)","journal-title":"JAMA"},{"key":"62_CR33","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/labinvest.3700136","volume":"84","author":"JL Juang","year":"2004","unstructured":"Juang JL, Chen TC, Jiang SS, Hsiong CA, Chen WC, Cheng GW, Lin SM, Lin JH, Chiu SC, Lai YK (2004) Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome coronavirus. Lab Invest 84:1085\u20131091","journal-title":"Lab Invest"},{"key":"62_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0166-0934(03)00193-9","volume":"112","author":"M Laassri","year":"2003","unstructured":"Laassri M, Chizhikov V, Mikheev M, Shchelkunov S, Chumakov K (2003) Detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides. J Virol Methods 112:67\u201378","journal-title":"J Virol Methods"},{"key":"62_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0166-0934(99)00135-4","volume":"84","author":"DC Lee","year":"2000","unstructured":"Lee DC, Stenland CJ, Hartwell RC, Ford EK, Cai K, Miller JL, Gilligan KJ, Rubenstein R, Fournel M, Petteway SR (2000) Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods 84:77\u201389","journal-title":"J Virol Methods"},{"key":"62_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","volume":"363","author":"CA Llewelyn","year":"2004","unstructured":"Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, MacKenzie J, Will RG (2004) Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion. Lancet 363:417\u2013421","journal-title":"Lancet"},{"key":"62_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<555::AID-IJC19>3.0.CO;2-2","volume":"83","author":"RA MacLeod","year":"1999","unstructured":"MacLeod RA, Dirks WG, Matsuo Y, Kaufmann M, Milch H, Drexler HG (1999) Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83:555\u2013563","journal-title":"Int J Cancer"},{"key":"62_CR38","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1136\/bmj.328.7451.1277-a","volume":"328","author":"S Mayor","year":"2004","unstructured":"Mayor S (2004) First stem cell bank in the world is opened in UK. BMJ 328:1277","journal-title":"BMJ"},{"key":"62_CR39","first-page":"99","volume-title":"Advances in cell cultures, vol. 2","author":"GJ McGarrity","year":"1982","unstructured":"McGarrity GJ (1982) Detection of mycoplasmal infection of cell cultures. In: Maramorosch K (ed) Advances in cell cultures, vol. 2. Academic, New York, pp 99\u2013131"},{"key":"62_CR40","first-page":"445","volume-title":"Mycoplasmas\u2014molecular biology and pathogenesis","author":"GJ McGarrity","year":"1992","unstructured":"McGarrity GJ, Kotani H, Butler GH (1992) Mycoplasmas and tissue culture cells. In: Maniloff J, McElhaney RN, Fich LR, Baseman JB (eds) Mycoplasmas\u2014molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C., pp 445\u2013454"},{"key":"62_CR41","unstructured":"Microbiological Control Methods (2003) In the European Pharmacopeia: present and future. European Directorate for the Quality of Medicines Meeting, Copenhagen, pp 5\u20137 and 29\u201331"},{"key":"62_CR42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/B978-012426291-1\/50019-4","volume-title":"Non isotopic probing, plotting and sequencing","author":"NC Nelson","year":"1995","unstructured":"Nelson NC, Reynolds MA, Arnold LJ Jr (1995) Detection of acridinium esters by chemiluminescence. In: Kricka LJ (ed) Non isotopic probing, plotting and sequencing. Academic, San Diego, CA, pp 391\u2013428"},{"key":"62_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1126\/science.6451928","volume":"212","author":"WA Nelson-Rees","year":"1981","unstructured":"Nelson-Rees WA, Daniels DW, Flandermeyer RR (1981) Cross-contamination of cells in culture. Science 212:446\u2013452","journal-title":"Science"},{"key":"62_CR44","first-page":"234","volume-title":"Manual of clinical microbiology","author":"FS Nolte","year":"2003","unstructured":"Nolte FS, Caliendo AM (2003) Molecular detection and identification of microorganisms. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. ASM, Washington, D.C., pp 234\u2013256"},{"key":"62_CR45","first-page":"185","volume-title":"Manual of clinical microbiology","author":"CM O'Hara","year":"2003","unstructured":"O'Hara CM, Weinstein MP, Miller JM (2003) Manual and automated systems for detection and identification of microorganisms. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. ASM, Washington, D.C., pp 185\u2013207"},{"key":"62_CR46","volume-title":"Parenteral Society Technical Monograph No 2. Environmental contamination control practice","author":"Parenteral Society","year":"2002","unstructured":"Parenteral Society (2002) Parenteral Society Technical Monograph No 2. Environmental contamination control practice. Parenteral Society, London"},{"key":"62_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","volume":"264","author":"AH Peden","year":"2004","unstructured":"Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 264:527\u2013529","journal-title":"Lancet"},{"key":"62_CR48","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(04)16341-1","volume":"363","author":"S Pincock","year":"2004","unstructured":"Pincock S (2004) UK opens embryonic stem cell bank. Lancet 363:1778","journal-title":"Lancet"},{"key":"62_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1006\/mcpr.1994.1071","volume":"8","author":"S Razin","year":"1994","unstructured":"Razin S (1994) DNA probes and PCR in diagnosis of mycoplasma infections. Mol Cell Probes 8:497\u2013511","journal-title":"Mol Cell Probes"},{"key":"62_CR50","unstructured":"Rijsewijk F, Maris-Veldhuis MA, Oei HL, Claassen I (2002) Semi-quantitative detection of BVDV RNA in vaccine samples using RT-PCR with internal control RNA molecules. ID-lelystad\/CIDC"},{"key":"62_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1386-6532(00)00149-9","volume":"20","author":"J Saldanha","year":"2001","unstructured":"Saldanha J (2001) Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. J Clin Virol 20:7\u201313","journal-title":"J Clin Virol"},{"key":"62_CR52","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","volume":"334","author":"GB Schreiber","year":"1996","unstructured":"Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334:1685\u20131690","journal-title":"N Engl J Med"},{"key":"62_CR53","first-page":"58","volume-title":"Cell and tissue culture for medical research, chapter 2","author":"GN Stacey","year":"2000","unstructured":"Stacey GN (2000) Detection of mycoplasma by DNA amplification. In: Doyle A, Griffitths JB (eds) Cell and tissue culture for medical research, chapter 2. Wiley, New York, pp 58\u201361"},{"key":"62_CR54","first-page":"141","volume":"98","author":"GN Stacey","year":"1999","unstructured":"Stacey GN, Phillips P (1999) Quality assurance for cell substrates. Dev Biol Stand 98:141\u2013151","journal-title":"Dev Biol Stand"},{"key":"62_CR55","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/35000394","volume":"403","author":"GN Stacey","year":"2000","unstructured":"Stacey GN, Masters JRW, Hay RJ, Drexler HG, MacLeod RAF, Freshney RI (2000) Cell contamination leads to inaccurate data: we must take action now. Nature 403:356","journal-title":"Nature"},{"key":"62_CR56","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1056\/NEJMoa040085","volume":"351","author":"SL Stramer","year":"2004","unstructured":"Stramer SL, Glynn SA, Kleinman SH, Strong M, Caglioti S, Wright DJ, Dodd RY, Busch MP (2004) Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N Engl J Med 351:760\u2013768","journal-title":"N Engl J Med"},{"key":"62_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0166-0934(95)01993-6","volume":"58","author":"H Takeuchi","year":"1996","unstructured":"Takeuchi H, Kobayashi R, Hasegawa M, Hirai K (1996) Detection of latent infection by Epstein\u2013Barr virus in peripheral blood cells of healthy individuals and in non-neoplastic tonsillar tissue from patients by reverse transcription-polymerase chain reaction. J Virol Methods 58:81\u201389","journal-title":"J Virol Methods"},{"key":"62_CR58","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11626-998-0014-0","volume":"34","author":"LH Toji","year":"1998","unstructured":"Toji LH, Lenchitz TC, Kwiatkowski VA, Sarama JA, Mulivor RA (1998) Validation of routine mycoplasma testing by PCR. In Vitro Cell Dev Biol, Anim 34:356\u2013358","journal-title":"In Vitro Cell Dev Biol, Anim"},{"key":"62_CR59","volume-title":"Providing tissues of human origin for therapeutic purposes","author":"UK Code of Practice for Tissue Banks","year":"2001","unstructured":"UK Code of Practice for Tissue Banks (2001) Providing tissues of human origin for therapeutic purposes, Department of Health, Crown"},{"key":"62_CR60","unstructured":"UK MSBT (2000) Guidelines on the microbiological safety of human organs, tissues and cells used in transplantation. Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation, MSBT"},{"key":"62_CR61","volume-title":"Guidelines for the blood transfusion services in the United Kingdom (Red Book)","author":"UKBTS\/NIBSC","year":"2002","unstructured":"UKBTS\/NIBSC (2002) Guidelines for the blood transfusion services in the United Kingdom (Red Book), 6th edn. UKBTS\/NIBSC, London","edition":"6"},{"key":"62_CR62","first-page":"13","volume":"290","author":"CC Uphoff","year":"2005","unstructured":"Uphoff CC, Drexler HG (2005) Detection of mycoplasma contaminations. Methods Mol Biol 290:13\u201323","journal-title":"Methods Mol Biol"},{"key":"62_CR63","volume-title":"CFR (Code of Federal Regulations) section 1271 Subpart C-suitability determination for donors of human cellular and tissue based products, proposed rule 64 FR 189","author":"US Food and Drugs Administration","year":"1999","unstructured":"US Food and Drugs Administration (1999) CFR (Code of Federal Regulations) section 1271 Subpart C-suitability determination for donors of human cellular and tissue based products, proposed rule 64 FR 189. US Food and Drugs Administration, Rockville, MD"},{"key":"62_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","volume":"358","author":"JD Wadsworth","year":"2001","unstructured":"Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt\u2013Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171\u2013180","journal-title":"Lancet"},{"key":"62_CR65","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1128\/jb.171.12.6455-6467.1989","volume":"171","author":"WG Weisburg","year":"1989","unstructured":"Weisburg WG, Tully JG, Rose DL, Petzel P, Oyaizu H, Yang D, Mandelco L, Sechrest J, Lawrence TG, Van Etten J, Maniloff J, Woese CR (1989) A phylogenetic analysis of the mycoplasmas: basis of their classification. J Bacteriol 171:6455\u20136467","journal-title":"J Bacteriol"},{"key":"62_CR66","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1056\/NEJMoa032510","volume":"351","author":"S Zou","year":"2004","unstructured":"Zou S, Dodd RY, Stramer SL, Strong M (2004) Probability of viremia with HBV, HCV, HIV and HTLV among tissue donors in the United States. N Eng J Med 351:751\u2013759","journal-title":"N Eng J Med"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-005-0062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-005-0062-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-005-0062-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-005-0062-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:15:04Z","timestamp":1744161304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-005-0062-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,13]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s00253-005-0062-2","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,13]]},"assertion":[{"value":"9 April 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}